[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335467-105":59,"doc-detail-335467-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","human-cytomegalovirus-infection-among-febrile-hematological-cancer-patients-at-the-uganda-cancer-institute","Human cytomegalovirus infection among febrile hematological cancer patients at the Uganda Cancer Institute","","Hematological cancers such as leukemias and lymphomas, together with their chemotherapy and disease-specific factors, impair granulocyte numbers and function, increasing opportunistic infection risk that frequently presents as fever. Human cytomegalovirus (HCMV) is an important opportunistic pathogen in these patients, yet Uganda data on seroprevalence and active infection burden remain limited. A cross-sectional study (June–August 2017) at the Uganda Cancer Institute tested 161 febrile patients: IgG/IgM ELISA assessed exposure and PCR with gel electrophoresis confirmed active infection. Overall HCMV seroprevalence was 66% (IgG/IgM), with 14.3% showing active infection.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/human-cytomegalovirus-infection-among-febrile-hematological-cancer-patients-at-the-uganda-cancer-institute/335467/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/human-cytomegalovirus-infection-among-febrile-hematological-cancer-patients-at-the-uganda-cancer-institute/335467.png","ImageObject",300,407,{"name":92,"@type":93},"Skyler","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-15","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the study purpose regarding HCMV in febrile hematological cancer patients in Uganda?","Question",{"text":112,"@type":113},"To determine HCMV seroprevalence and the burden of active HCMV infection among febrile hematological cancer patients at the Uganda Cancer Institute.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were HCMV exposure and active infection measured?",{"text":117,"@type":113},"Exposure was assessed using indirect ELISA for IgG and IgM antibodies, and active infection was confirmed with PCR testing followed by gel electrophoresis.",{"name":119,"@type":110,"acceptedAnswer":120},"What proportions of patients showed serological exposure and active HCMV infection?",{"text":121,"@type":113},"HCMV seroprevalence (IgG and/or IgM) was 66% overall, HCMV DNA PCR was positive in 3% of samples, and active infection based on IgM and HCMV DNA PCR was found in 14.3% of patients.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335467,1791303333,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},2336464648746,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","| Clinical Microbiology | Research Article  \nHuman cytomegalovirus infection among febrile hematological cancer patients at the Uganda Cancer Institute  \nOcung Guido,1,2 Margaret Lubwama,3 Prossy Kiconco,4 Alfred Okeng,4 Irene Najjingo,5 Emmanuel Aboce,4 Rembo Phiona,6 Hanifah Nabbanja,6 Mariam Ndagire,6 Kamala Eva,6 Wekiya Enock,2 Jackson Orem,6 Moses L. Joloba,1,2 Freddie Bwanga1,4  \nAUTHOR AFFILIATIONS See affiliation list on p. 9.  \nABSTRACT Hematological cancers, including Leukemias and Lymphomas, and their associated chemotherapy and disease-specific factors, are linked to impaired granulocyte function and numbers, increasing the risk of opportunistic infections, often presenting as fever. Human cytomegalovirus (HCMV) is one of the significant opportunistic infections in these patients, but limited data exists on its seroprevalence and active infection burden among febrile hematological cancer patients in Uganda. We conducted a cross-sectional study from June to August 2017 at the Uganda Cancer Institute (UCI) . Blood samples from 161 febrile hematological cancer patients were collected. HCMV exposure was assessed using indirect enzyme-linked immunosorbent assay for IgG and IgM antibodies, and active infection was confirmed with PCR testing and gel electrophoresis. IgG positivity indicated previous exposure, while positive IgM or PCR results indicated active infection. Overall, HCMV seroprevalence based on IgG and/or IgM positivity was 106/161 (66%) . IgG alone, IgM alone, and combined IgG/IgM positivity prevalence rates were 57/161 (35.4%), 22/161 (13.6%), and 27/161 (16.7%), respectively. HCMV DNA PCR was positive in 5 of the 161 (3%) samples. Among PCR-positive patients, one (20%) was positive for IgG alone, two (40%) for IgM alone, and two (40%) for both IgG and IgM. Active infection based on positive IgM and HCMV DNA PCR was found in 23 of the 161 (14.3%) patients. Two-thirds of febrile patients with hematological malignancies in Uganda had been exposed to HCMV infection, with 14.3% showing active infection. Routine testing for active HCMV infection among febrile hematological cancer patients at the UCI is essential for timely and appropriate antiviral treatment.  \nIMPORTANCE In this paper, we demonstrated that over two-thirds of feverish patients with blood cancers such as leukemia at the Uganda Cancer Institute are already exposed to a type of virus infection called the human cytomegalovirus (HCMV), and 14% of the patients have active disease due to this virus. This was confirmed through finding blood samples testing positive for a type of protective antibody called IgM and also upon virus DNA detection in the blood of those patients. Routine testing for this virus is not usually done in the study settings. Our findings reveal and emphasize the importance of routinely testing blood samples for active infection with this virus among the feverish patients with blood cancers in the study settings, and prompt initiation of antiviral treatment of the actively infected patients  \nKEYWORDS Hematological malignancy, human cytomegalovirus, febrile illness, cancer chemotherapy, HCMV reactivation  \nS hould the current trends continue, cancer will soon surpass infectious diseases as  \nthe main cause of death and disability worldwide within the next few decades (1) . Based on GLOBOCAN estimates, there are 32.6 million people living with cancer (within 5 years of diagnosis), 14.1 million new cancer cases, and about 8.8 million deaths recorded  \nEditor Luciana Jesus Costa, Universidade Federal do Rio de, Janeiro, Rio de Janeiro, Brazil  \nAddress correspondence to Freddie Bwanga, [freddie.bwanga@gmail.com](freddie.bwanga@gmail.com).  \nOcung Guido and Freddie Bwanga contributed equally this work academically  \nworldwide as of 2015 (1–3) . This burden has shifted to less-developed countries, where it accounts for approximately 57% of new cancer cases, 65% of cancer deaths, and 48% of the 5-year prevalent cancer cases reported in 20","cbCairNneyaGh364","https://ap.wps.com/l/cbCairNneyaGh364","pdf",341231,11,"English","# Abstract\n## Study design and methods\n## Key results\n## Clinical implication","[{\"question\":\"What was the study purpose regarding HCMV in febrile hematological cancer patients in Uganda?\",\"answer\":\"To determine HCMV seroprevalence and the burden of active HCMV infection among febrile hematological cancer patients at the Uganda Cancer Institute.\"},{\"question\":\"How were HCMV exposure and active infection measured?\",\"answer\":\"Exposure was assessed using indirect ELISA for IgG and IgM antibodies, and active infection was confirmed with PCR testing followed by gel electrophoresis.\"},{\"question\":\"What proportions of patients showed serological exposure and active HCMV infection?\",\"answer\":\"HCMV seroprevalence (IgG and/or IgM) was 66% overall, HCMV DNA PCR was positive in 3% of samples, and active infection based on IgM and HCMV DNA PCR was found in 14.3% of patients.\"}]","Human cytomegalovirus infection among febrile hematological cancer patients at the Uganda Cancer Institute | PDF",1790011078,28]